![Kathryn Corzo](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kathryn Corzo
Direktor/Vorstandsmitglied bei
MARKER THERAPEUTICS, INC.
Vermögen: - $ am 31.05.2026
Profil
Kathryn Penkus Corzo is currently an Independent Director at Marker Therapeutics, Inc. since 2025.
Former positions include Independent Director at Matinas BioPharma Holdings, Inc. from 2021 to 2024; Director at Maverick Therapeutics, Inc. from 2020 to 2021; Head-Oncology Cell Therapy Development at Takeda Pharmaceutical Co., Ltd. from 2020 to 2021; Vice President at Genzyme Corp.
from 2010 to 2019; Director-Clinical Liaison & Medical Communications at Syndax Pharmaceuticals, Inc. from 2008 to 2010; Principal at Eli Lilly & Co. from 1989 to 2010; Principal at Hoffman-LaRoche F & Co. AG from 1989 to 2000; Partner at Takeda Ventures, Inc.; and President & Chief Operating Officer at Bit Bio Ltd. Education includes an undergraduate degree from Massachusetts College of Pharmacy & Health Science and an MBA from MIT Sloan School of Management.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 01.03.2026 | 0 ( -.--% ) | - $ | 31.05.2026 |
Aktive Positionen von Kathryn Corzo
| Unternehmen | Position | Beginn |
|---|---|---|
| MARKER THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.11.2025 |
Ehemalige bekannte Positionen von Kathryn Corzo
| Unternehmen | Position | Ende |
|---|---|---|
| MATINAS BIOPHARMA HOLDINGS, INC. | Direktor/Vorstandsmitglied | 22.11.2024 |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Corporate Officer/Principal | 01.10.2021 |
Maverick Therapeutics, Inc.
 Maverick Therapeutics, Inc. BiotechnologyHealth Technology Operates as a preclinical stage biotech company which develops T cell redirecting antibody therapeutics | Direktor/Vorstandsmitglied | 01.03.2021 |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Corporate Officer/Principal | 01.01.2019 |
| SYNDAX PHARMACEUTICALS, INC. | Public Communications Contact | 25.01.2010 |
Ausbildung von Kathryn Corzo
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
91
Beziehungen ersten Grades
12
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 12 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Marker Therapeutics, Inc.
 Marker Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes cell based immune therapeutics and vaccines for cancer treatment | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Syndax Pharmaceuticals, Inc.
 Syndax Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
Matinas BioPharma Holdings, Inc.
 Matinas BioPharma Holdings, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Takeda Pharmaceutical Co., Ltd.
 Takeda Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research, development, manufacturing and marketing of pharmaceutical products | Health Technology |
Massachusetts College of Pharmacy & Health Science
 Massachusetts College of Pharmacy & Health Science Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hoffman-LaRoche F & Co. AG
 Hoffman-LaRoche F & Co. AG Miscellaneous Commercial ServicesCommercial Services Hoffman-LaRoche F & Co. AG is a Swiss company. | Commercial Services |
Takeda Ventures, Inc.
 Takeda Ventures, Inc. Investment ManagersFinance Takeda Ventures invests in companies located across the globe. The firm focuses on high-caliber, therapeutic, platform-based companies. It provides financing for early stage capital requirements. | Finance |
MIT Sloan School of Management
 MIT Sloan School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Maverick Therapeutics, Inc.
Maverick Therapeutics, Inc. BiotechnologyHealth Technology Operates as a preclinical stage biotech company which develops T cell redirecting antibody therapeutics | Health Technology |
Bit Bio Ltd.
 Bit Bio Ltd. BiotechnologyHealth Technology Operates as a biology company that providing human cells for research, drug discovery and cell therapy | Health Technology |
